This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Amplidiag Oy. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Hilpi Rautelin: Innovator in PCR-Based Detection Methods
Introduction
Hilpi Rautelin is a notable inventor based in Helsinki, Finland. She has made significant contributions to the field of medical diagnostics, particularly in the detection of chronic gastritis-causing bacteria. Her innovative approach utilizes advanced molecular techniques to improve diagnostic accuracy.
Latest Patents
Hilpi Rautelin holds a patent for a PCR-based method designed to detect chronic gastritis-causing bacteria in stool samples. This invention is based on the use of oligonucleotide primers and probes that are specific to the 23S rRNA gene. This method enhances the ability to identify the presence of harmful bacteria, thereby facilitating timely and effective treatment.
Career Highlights
Hilpi is currently associated with Amplidiag Oy, a company that focuses on developing diagnostic solutions. Her work at Amplidiag Oy has allowed her to apply her expertise in molecular biology to create impactful health solutions. She has been recognized for her innovative contributions to the field.
Collaborations
Hilpi collaborates with Juha Kirveskari, who is also involved in the research and development of diagnostic methods. Their partnership has fostered a productive environment for innovation and advancement in medical diagnostics.
Conclusion
Hilpi Rautelin's work exemplifies the importance of innovation in healthcare. Her contributions to PCR-based detection methods are paving the way for improved diagnostic practices.